Authentication
Sign In
Facebook Connect
Create account
Dashboard
Providers
Publications
Networks
Clusters
Virtual Clinics
Directories
ask Dr Jenny
Cancer
Cosmetic Surgery
Dentistry
Diabetes
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Haematology
Healthcare
Health Policy
Heart disease
Hepatology
Medical Technology
Medicine
Nephrology
Neurosurgery
Obstetrics and Gynaecology
Ophthalmology
Orthopaedics
Paediatrics
Palliative Care
Patients' Voices
Plastic and Reconstructive Surgery
Pregnancy & childbirth
Preventive medicine
Pulmonology
Radiotherapy
Rheumatology
STD
Urology
Vascular Disease
Weight Management
Library
You must log in to use
this feature.
My Account
Create account
Sign In
Facebook Connect
Tag
Tagged:
molecular targets
Sponsored
10 years, 3 months ago
9958
0
Facebook
Twitter
Google+
LinkedIn
Report
What is tumor banking?
Maria Paola Costi
Directory:
Cancer
Tags:
biobanks
EUTROC
molecular targets
ovarian cancer
personalized medicine
tissue samples
translational research
tumor banks
tumor profiling
virtual tumor banks
view in full page
10 years, 3 months ago
9182
0
Facebook
Twitter
Google+
LinkedIn
Report
Is tumor banking developed sufficiently to assemble the quantity and quality of appropriate data and tissue in a timely and effective way?
Maria Paola Costi
Directory:
Cancer
Tags:
biobanks
EUTROC
molecular targets
ovarian cancer
personalized medicine
tissue samples
translational research
tumor banks
tumor profiling
virtual tumor banks
view in full page
10 years, 3 months ago
13156
0
Facebook
Twitter
Google+
LinkedIn
Report
Why are high throughput technologies helpful in the treatment of ovarian cancer?
Christophe Le Tourneau
Directory:
Cancer
Tags:
EUTROC
high throughput technology
metastatic cancer
molecular targets
mutation
ovarian cancer
refractory cancer
SHIVA trial
translational research
tumor profiling
view in full page
10 years, 3 months ago
8773
0
Facebook
Twitter
Google+
LinkedIn
Report
What is the current status of personalised medicine?
Jaume Reventos
Directory:
Cancer
Tags:
biobanks
EUTROC
genetic targets
molecular targets
ovarian cancer
personalized medicine
tissue samples
translational research
tumor banks
tumor profiling
view in full page
10 years, 3 months ago
10478
0
Facebook
Twitter
Google+
LinkedIn
Report
To what extent do the relative low flow of data and information between clinical groups and institutions impede ovarian cancer research?
Robert Zeillinger
Directory:
Cancer
Tags:
data flow
EUTROC
molecular targets
ovarian cancer
personalized medicine
tissue samples
translational research
tumor banks
tumor profiling
virtual tumor banks
view in full page